AstraZeneca to advance Oxford’s COVID-19 vaccine with $1bn investment
AstraZeneca is going to expedite the development of the University of Oxford investigational COVID-19 vaccine with a $1 billion BARDA
Read more
COVID-19
Coronavirus (COVID-19) pharmaceutical industry updates
Read the latest pharmaceutical industry press releases, news updates and articles on coronavirus COVID-19 medical treatment, therapies and drug and vaccine development.
ACTide EDC (Electronic Data Capture) System against COVID-19
Nubilaria, a forward thinking clinical data management company, has released an important announcement for Researchers and Health Professionals in Europe
Read more
CEPI to fund Novavax COVID-19 vaccine with up to $388 Million
CEPI has increased its investment with up to $388 million for the Novavax COVID-19 (NVX‑CoV2373) vaccine development and manufacturing. Phase
Read more
Moderna’s mRNA COVID-19 vaccine (mRNA-1273) fast-tracked by FDA
Moderna, Inc., (Nasdaq: MRNA) a clinical-stage biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced on May 12, that
Read more
U.S. Congress invests heavily in big pharma stocks
U.S Congress members seem to like trading big pharma stocks. Pfizer is one of the most popular pharma stocks in
Read more
BioMed, Utrecht University and Erasmus discover antibody blocking SARS-CoV-2 in cells
Scientists at clinical-stage biopharmaceutical company Harbour BioMed (HBM), Utrecht University and Erasmus Medical Center announced that they have discovered a
Read more
Roche’s COVID-19 antibody test gets FDA emergency authorisation
Swiss pharma giant Roche has received Emergency Use Authorisation (EUA) from the FDA for its latest COVID-19 antibody test –
Read more
FDA issues emergency authorisation for remdesivir to treat COVID-19
The U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for emergency use of Gilead’s remdesivir
Read more
Moderna and Lonza partner up to manufacture COVID-19 vaccine
Moderna, a clinical-stage biotech developing messenger RNA (mRNA) therapeutics and vaccines, and Swiss pharma giant Lonza today announced the introduction
Read more
AstraZeneca and Oxford University agree to globalise COVID-19 vaccine
UK-headquartered AstraZeneca and Oxford University announced an agreement to develop and distribute the university’s future recombinant adenovirus vaccine to prevent
Read more